A post-hoc analysis of combined data from the two previous studies further confirmed that TGC had a significantly higher risk of hypoglycemia (which occurred in 11.3% of TGC patients versus 1.8% of those with conventional insulin therapy, p < 0.0001)41. Here, INS is linked to Hypoglycemia.